Suprdipine, >= 98%( HPLC ), solide

Code: i6658-5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Isradipine has been used to explore neuroprotective activity.

Biochem/physiol Actions

L-type calcium channel blocker (also referred t...


 En savoir plus

Votre prix
$238.28 5MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Isradipine has been used to explore neuroprotective activity.

Biochem/physiol Actions

L-type calcium channel blocker (also referred to as dihydropyridine-type calcium channel blocker); antihypertensive.

Isradipineis considered as an active calcium channel blocker, used to treat hypertension.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. I6658.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
coloryellow
descriptionStore under nitrogen
formsolid
Gene Informationhuman ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779), CACNA2D1(781)
InChI keyHMJIYCCIJYRONP-UHFFFAOYSA-N
InChI1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3
originatorNovartis
Quality Level100
SMILES stringCOC(=O)C1=C(C)NC(C)=C(C1c2cccc3nonc23)C(=O)OC(C)C
solubilityDMSO: >10 mg/mL
storage temp.2-8°C
Cas Number75695-93-1
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.